Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Dec 15;63(12):1680-1681.
doi: 10.1093/cid/ciw641. Epub 2016 Sep 22.

Role of K13 Mutations in Artemisinin-Based Combination Therapy

Charlotte Rasmussen  1 , Frédéric Ariey  2 , Rick M Fairhurst  3 , Pascal Ringwald  1 , Didier Ménard  4   5   6
Affiliations
Comment

Role of K13 Mutations in Artemisinin-Based Combination Therapy

Charlotte Rasmussen et al. Clin Infect Dis. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Phyo AP, Ashley EA, Anderson TJ et al. . Declining efficacy of artemisinin combination therapy against P. falciparum malaria on the Thai-Myanmar border (2003–2013): the role of parasite genetic factors. Clin Infect Dis 2016; 63:784–91. - PMC - PubMed
    1. Denis MB, Tsuyuoka R, Poravuth Y et al. . Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Trop Med Int Health 2006; 11:1360–6. - PubMed
    1. Leang R, Ros S, Duong S, Navaratnam V et al. . Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia. Malar J 2013; 12:343. - PMC - PubMed
    1. Wang Y, Yang Z, Yuan L et al. . Clinical efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria at the China-Myanmar border. Am J Trop Med Hyg 2015; 93:577–83. - PMC - PubMed
    1. Tun KM, Jeeyapant A, Imwong M et al. . Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin resistance phenotype: a therapeutic efficacy study. Malar J 2016; 15:185. - PMC - PubMed